- Home
- CMMB vs BATL Comparison
CMMB vs BATL Comparison
Compare CMMB & BATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- BATL
- Stock Information
- Founded
- CMMB 2004
- BATL 1987
- Country
- CMMB Israel
- BATL United States
- Employees
- CMMB N/A
- BATL N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- BATL Oil & Gas Production
- Sector
- CMMB Health Care
- BATL Energy
- Exchange
- CMMB Nasdaq
- BATL Nasdaq
- Market Cap
- CMMB 23.6M
- BATL 22.5M
- IPO Year
- CMMB N/A
- BATL N/A
- Fundamental
- Price
- CMMB $1.20
- BATL $1.23
- Analyst Decision
- CMMB Strong Buy
- BATL
- Analyst Count
- CMMB 2
- BATL 0
- Target Price
- CMMB $9.00
- BATL N/A
- AVG Volume (30 Days)
- CMMB 167.2K
- BATL 66.1K
- Earning Date
- CMMB 05-08-2025
- BATL 05-14-2025
- Dividend Yield
- CMMB N/A
- BATL N/A
- EPS Growth
- CMMB N/A
- BATL N/A
- EPS
- CMMB N/A
- BATL N/A
- Revenue
- CMMB N/A
- BATL $193,893,000.00
- Revenue This Year
- CMMB N/A
- BATL N/A
- Revenue Next Year
- CMMB N/A
- BATL N/A
- P/E Ratio
- CMMB N/A
- BATL N/A
- Revenue Growth
- CMMB N/A
- BATL N/A
- 52 Week Low
- CMMB $0.58
- BATL $1.05
- 52 Week High
- CMMB $2.55
- BATL $6.89
- Technical
- Relative Strength Index (RSI)
- CMMB 50.27
- BATL 45.65
- Support Level
- CMMB $1.08
- BATL $1.17
- Resistance Level
- CMMB $1.25
- BATL $1.39
- Average True Range (ATR)
- CMMB 0.11
- BATL 0.15
- MACD
- CMMB 0.04
- BATL 0.01
- Stochastic Oscillator
- CMMB 83.65
- BATL 23.68
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.
About BATL Battalion Oil Corporation
Battalion Oil Corp is an independent oil and gas producer operating exclusively in the Delaware Basin. It is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the United States. The company operates in one segment which focuses on oil and natural gas acquisition, production, exploration, and development.